Paradox: High HDL-C levels tied to higher mortality risk in CAD patients, JAMA Study
USA: Using data from two prospective cohort studies, in the U.K. and U.S., the researchers in a recent study revealed that both very low and very high HDL levels are associated with an increased risk of mortality. The study appears in the Journal of the American Medical Association - Cardiology.
The researchers state, "very high HDL-C levels are paradoxically associated with higher mortality risk in patients with coronary artery disease (CAD). This association was not dependent on the common polymorphisms associated with high HDL-C levels."
Previous studies have shown an inverse relationship between higher high-density lipoprotein cholesterol (HDL-C) levels and cardiovascular risk. However, recent data on the general population have shown an increased risk of adverse outcomes at very high concentrations of HDL-C. To verify the same, Chang Liu, Emory University School of Medicine, Atlanta, Georgia, and colleagues aimed to examine the association between very high HDL-C levels (>80 mg/dL) and mortality in CAD patients. They also investigated the association of known HDL-C genotypes with high HDL-C level outcomes.
For this purpose, the researchers conducted a prospective, multicenter, cohort study from 2006 to present in the UK and from 2003 to present in Atlanta, Georgia. They recruited patients with CAD from the UK Biobank (UKB) and the Emory Cardiovascular Biobank (EmCAB), respectively. Patients without confirmed CAD were not included. Data analyses were conducted from May 10, 2020, to April 28, 2021.
All-cause death was the primary outcome. The secondary outcome was cardiovascular death. The study included a total of 14 478 participants (mean age, 62.1 years; 11 034 men [76.2%]) from the UKB and 5467 participants (mean age, 63.8 years; 3632 men [66.4%]) from the EmCAB.
Based on the study, the researchers reported the following:
- Over a median follow-up of 8.9 years in the UKB and 6.7 years in the EmCAB, a U-shaped association with outcomes was observed with higher risk in those with both low and very high HDL-C levels compared with those with midrange values.
- Very high HDL-C levels (>80 mg/dL) were associated with an increased risk of all-cause death (hazard ratio [HR], 1.96) and cardiovascular death (HR, 1.71) compared with those with HDL-C levels in the range of 40 to 60 mg/dL in the UKB after adjustment for confounding factors.
- These results were replicated in the EmCAB.
- These associations persisted after adjustment for the HDL-C genetic risk score within the UKB.
- Sensitivity analyses demonstrated that the risk of all-cause mortality in the very high HDL-C group was higher among men than women in the UKB (HR, 2.63 vs HR, 1.39).
The researchers conclude, "results of this cohort study indicate that very high HDL-C levels are paradoxically associated with higher mortality risk in CAD patients. This association was independent of the common polymorphisms associated with high HDL-C levels."
Reference:
Liu C, Dhindsa D, Almuwaqqat Z, et al. Association Between High-Density Lipoprotein Cholesterol Levels and Adverse Cardiovascular Outcomes in High-risk Populations. JAMA Cardiol. Published online May 18, 2022. doi:10.1001/jamacardio.2022.0912
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.